G. Cotzias, P. Papavasiliou, and R. Gellene, Modification of Parkinsonism ??? Chronic Treatment with L-Dopa, New England Journal of Medicine, vol.280, issue.7, pp.337-345, 1969.
DOI : 10.1056/NEJM196902132800701

P. Jenner, Molecular mechanisms of L-DOPA-induced dyskinesia, Nature Reviews Neuroscience, vol.68, issue.9, pp.665-677, 2008.
DOI : 10.1038/nrn2471

I. Aubert, C. Guigoni, K. Hakansson, L. Qin, and S. Dovero, dopamine receptor signaling in levodopa-induced dyskinesia, Annals of Neurology, vol.12, issue.1, pp.17-26, 2005.
DOI : 10.1002/ana.20296

B. Picconi, D. Centonze, K. Hakansson, G. Bernardi, and P. Greengard, Loss of bidirectional striatal synaptic plasticity in L-DOPA???induced dyskinesia, Nature Neuroscience, vol.6, pp.501-506, 2003.
DOI : 10.1038/nn1040

N. Pavon, A. Martin, A. Mendialdua, and R. Moratalla, ERK Phosphorylation and FosB Expression Are Associated with L-DOPA-Induced Dyskinesia in Hemiparkinsonian Mice, Biological Psychiatry, vol.59, issue.1, pp.64-74, 2006.
DOI : 10.1016/j.biopsych.2005.05.044

E. Santini, E. Valjent, A. Usiello, M. Carta, and A. Borgkvist, Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced Dyskinesia, Journal of Neuroscience, vol.27, issue.26, pp.6995-7005, 2007.
DOI : 10.1523/JNEUROSCI.0852-07.2007

J. Westin, L. Vercammen, E. Strome, C. Konradi, and M. Cenci, Spatiotemporal Pattern of Striatal ERK1/2 Phosphorylation in a Rat Model of L-DOPA???Induced Dyskinesia and the Role of Dopamine D1 Receptors, Biological Psychiatry, vol.62, issue.7, 2007.
DOI : 10.1016/j.biopsych.2006.11.032

C. Gerfen, S. Miyachi, R. Paletzki, and P. Brown, D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase, J Neurosci, vol.22, pp.5042-5054, 2002.

E. Bezard, S. Ferry, U. Mach, H. Stark, and L. Leriche, Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function, Nature Medicine, vol.9, issue.6, pp.762-767, 2003.
DOI : 10.1038/nm875

E. Bezard, S. Dovero, C. Prunier, P. Ravenscroft, and S. Chalon, Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease, J Neurosci, vol.21, pp.6853-6861, 2001.

A. Nadjar, J. Brotchie, C. Guigoni, Q. Li, and S. Zhou, Phenotype of Striatofugal Medium Spiny Neurons in Parkinsonian and Dyskinetic Nonhuman Primates: A Call for a Reappraisal of the Functional Organization of the Basal Ganglia, Journal of Neuroscience, vol.26, issue.34, pp.8653-8661, 2006.
DOI : 10.1523/JNEUROSCI.2582-06.2006

P. Fernagut, Q. Li, S. Dovero, P. Chan, and T. Wu, Dopamine transporter binding is unaffected by chronic L-DOPA treatment: relevance to imaging studies, 2010.

M. Ahmed, A. Berthet, E. Bychkov, G. Porras, and Q. Li, Lentiviral Overexpression of GRK6 Alleviates L-Dopa-Induced Dyskinesia in Experimental Parkinson's Disease, Science Translational Medicine, vol.2, issue.28, pp.28-28, 2010.
DOI : 10.1126/scitranslmed.3000664

O. Berton, C. Guigoni, Q. Li, B. Bioulac, and I. Aubert, Striatal Overexpression of ??JunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease, Biological Psychiatry, vol.66, issue.6, pp.554-561, 2009.
DOI : 10.1016/j.biopsych.2009.04.005

G. Snyder, J. Girault, J. Chen, A. Czernik, and J. Kebabian, Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine, J Neurosci, vol.12, pp.3071-3083, 1992.

K. Roche, O. Brien, R. Mammen, A. Bernhardt, J. Huganir et al., Characterization of Multiple Phosphorylation Sites on the AMPA Receptor GluR1 Subunit, Neuron, vol.16, issue.6, pp.1179-1188, 1996.
DOI : 10.1016/S0896-6273(00)80144-0

P. Roux, D. Shahbazian, H. Vu, M. Holz, and M. Cohen, RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation, Journal of Biological Chemistry, vol.282, issue.19, pp.14056-14064, 2007.
DOI : 10.1074/jbc.M700906200
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618456

E. Santini, M. Heiman, P. Greengard, E. Valjent, and G. Fisone, Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia, Science Signaling, vol.2, issue.80, p.36, 2009.
DOI : 10.1126/scisignal.2000308

E. Santini, C. Alcacer, S. Cacciatore, M. Heiman, and D. Herve, l-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice, Journal of Neurochemistry, vol.20, issue.3, pp.621-633, 2009.
DOI : 10.1111/j.1471-4159.2008.05831.x

J. Corvol, M. Muriel, E. Valjent, J. Feger, and N. Hanoun, Persistent Increase in Olfactory Type G-Protein ?? Subunit Levels May Underlie D1 Receptor Functional Hypersensitivity in Parkinson Disease, Journal of Neuroscience, vol.24, issue.31, pp.7007-7014, 2004.
DOI : 10.1523/JNEUROSCI.0676-04.2004

D. Kim, R. Palmiter, A. Cummins, and C. Gerfen, Reversal of supersensitive striatal dopamine D1 receptor signaling and extracellular signal-regulated kinase activity in dopamine-deficient mice???, Neuroscience, vol.137, issue.4, pp.1381-1388, 2006.
DOI : 10.1016/j.neuroscience.2005.10.054